Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer
Amir Karimzadeh, Kimberley Hansen, Ergela Hasa, Bernhard Haller, Matthias M. Heck, Robert Tauber, Calogero D`Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.